Reference
- Nasu S, et al. Skin Rash Can Be a Useful Marker for Afatinib Efficacy. Anticancer Research 38: 1783-1788, No. 3, Mar 2018. Available from: URL: http://doi.org/10.21873/anticanres.12416 - JapanPubMedGoogle Scholar
Copyright information
© Springer International Publishing AG, part of Springer Nature 2018